Excluded
DCF
Free cash flow, growth, discount rate, and terminal growth form an intrinsic value range.
---
-Positive free-cash-flow history is shorter than two years.
I
Financial ServicesCapital MarketsAustralia
IREN Limited (IREN) Valuation Assumptions
Review IREN Limited (IREN) valuation assumptions across intrinsic value, DCF, reverse DCF implied growth, EV/EBITDA, P/FCF, and financial trends.
NMS · US · USD
Latest price61.20 USD
30D+49.45%
Price vs model medianLimited model referenceModel median is the median base output from applicable absolute models, excluding Reverse DCF.
What price implies
What does the current price imply?
At 61.20 USD, the model implies roughly - annual FCF growth for 10 years, with required long-term operating margin near Assumption unavailable and terminal growth around 3%. This module is a research reference.
Implied FCF CAGR-
10-year Reverse DCF scenario
Required long-term operating marginAssumption unavailable
Five-year median × 0.95
Implied terminal growth3%
From current model assumptions
Discount rate assumption9%
Estimated from current sector rules
Historical valuation multiples
How have EV/EBITDA and P/FCF changed over the last 5 years?
Annual fiscal-period anchored: month-end prices are paired with the most recent annual fiscal period ending on or before each date, covering the last 5 years (35 monthly samples). Multiples are research references; financial-sector or otherwise non-comparable companies require sector-specific context.
P/E
Market cap divided by reported net income (annual fiscal-period snapshot).
157x
Above history · P96
Current5Y medianTypical range IQR
5Y median111x
Current157x · P96
5Y low 37.41xCurrent vs median+41.57%5Y high 157x
IQR 83.02–127x · 12 monthly samples
EV/EBITDA
Enterprise value (market cap + debt − cash) divided by EBITDA.
70.86x
Above history · P99
Current5Y medianTypical range IQR
5Y median18.62x
Current70.86x · P99
5Y low 3.07xCurrent vs median+280%5Y high 70.86x
IQR 8.9–40.58x · 35 monthly samples
Month-end historical multiples
A date-friendly view for historical EV/EBITDA, P/FCF, and P/E queries.
Showing 8 of 35 month-end samples
| Month-end | Price | P/E | P/FCF | EV/EBITDA | Fiscal period used |
|---|---|---|---|---|---|
| 2026-05-08 | 61.20 USD | 157x | - | 70.86x | 2025-06-30 |
| 2026-04-30 | 45.51 USD | 117x | - | 53.21x | 2025-06-30 |
| 2026-03-31 | 34.28 USD | 88.02x | - | 40.57x | 2025-06-30 |
| 2026-02-27 | 40.95 USD | 105x | - | 48.08x | 2025-06-30 |
| 2026-01-30 | 53.74 USD | 138x | - | 62.46x | 2025-06-30 |
| 2025-12-31 | 37.77 USD | 96.99x | - | 44.5x | 2025-06-30 |
| 2025-11-28 | 47.81 USD | 123x | - | 55.79x | 2025-06-30 |
| 2025-10-31 | 60.75 USD | 156x | - | 70.35x | 2025-06-30 |
Valuation overview
How do the valuation assumptions fit together?
IREN Limited (IREN) valuation on TickerVal is designed to help readers understand the operating expectations embedded in the current market price. At 61.20 USD, the page brings intrinsic value analysis, DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, and valuation assumptions into one research view within the Financial Services sector and the Capital Markets industry. Instead of treating one model as a final answer, TickerVal compares cash-flow, earnings-power, balance-sheet, and relative-multiple lenses so the differences between models are visible. The reverse DCF view currently shows implied growth of not available, while the model median reference sits at a limited composite reference versus the current price. The DCF and reverse DCF sections focus on free cash flow, discount rate, terminal growth, and the long-term growth path implied by the current price. EV/EBITDA and P/FCF provide additional context for capital structure and cash-flow multiples. The financial trends section connects those valuation assumptions back to reported revenue of 501M USD, free cash flow of -295M USD, margins, and balance-sheet facts from public filings. Readers can use the layout to compare assumptions across models before reviewing the underlying source data. This page is intended for transparent research reference, model review, and assumption checking.
Valuation model range vs. current price
Each row shows a model output range, with a vertical line for the current price.
Graham NumberCalculated · Limited reference
8.45 USD-8.45 USD
Current price reference line
Why do valuation models give different answers?
Different models rely on different financial facts. The status blocks show which lenses fit this page data.
| Model | Fit | Context |
|---|---|---|
| DCF | Not meaningful | For financial companies, cash-flow models are a limited research reference; balance-sheet lenses carry more context. |
| Owner Earnings | Not meaningful | Owner-earnings proxies are not meaningful for financial balance-sheet businesses. |
| Reverse DCF | Not meaningful | Reverse DCF is a limited scenario lens for financial companies. |
| Earnings Power Value | Not meaningful | Earnings power value depends on operating profit, which is not the main lens for this sector. |
| Graham Number | Limited | Works best when EPS and book value are both positive. |
| Dividend Discount Model | Not meaningful | Needs explicit dividend history, which is not included in the current version. |
| Net-Net Liquidation Value | Not meaningful | Requires current asset and liability detail beyond the current data set. |
| PEG | Not meaningful | A quick growth multiple lens when EPS history is positive. |
| EV/EBITDA | Not meaningful | EV/EBITDA is not meaningful for financial balance-sheet businesses. |
| P/FCF | Not meaningful | P/FCF is a limited research reference for financial companies. |
| P/B | Suitable | A balance-sheet lens is more relevant for financial companies. |
| P/S | Limited | A revenue multiple lens when profit or FCF is not stable. |
| Peer Comparison | Not meaningful | Standardized peer comparisons are not included in the current version. |
Which valuation models are being calculated?
Hover each model row to inspect formulas and inputs.
Current price61.20 USD
Model median referenceLimited model reference
Price vs model medianLimited model reference
Price date2026/05/08
The aggregated models are mostly limited-reference views, so the composite range bar is not shown.
Excluded
Owner Earnings
Uses net income, D&A, and capex as an owner-earnings proxy.
---
-Owner earnings samples are insufficient.
Excluded
Reverse DCF
Solves the forward FCF growth rate implied by the current price.
Implied growth-
-
-Positive free-cash-flow samples are insufficient.
Calculated
Earnings Power Value
Estimates earnings power value without assuming growth.
-1.44 USD-1.44 USD-1.44 USD
-1.44 USDCurrent price is 4347.9% below the base model value.
Updated: 2026/05/10
Which financial trends support the assumptions?
Annual financial metrics with switchable views. · Unit: USD
FY2025 · Jun 2025 report13 records
Revenue501M USD
Net income87M USD
Free cash flow-295M USD
CapEx573M USD
Operating cash flow246M USD
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
ExpandCollapse
Valuation basis and non-recurring items
Collapsed by default. Expand to inspect structured one-time items and adjusted figures without making them the primary page focus.
A positive amountAfterTax means the item increased reported net income; a negative value means it reduced reported net income. Adjusted net income = reported net income minus total after-tax impact. Valuation defaults to reported figures; adjusted figures are shown to observe one-time-item impact.
| Period | Item | Category | After-tax impact | Confidence |
|---|---|---|---|---|
| 2025/06/30 | Asset impairment | Impairment | -6M USD | Medium |
| 2025/06/30 | Asset sale gain/loss | Asset sale gain/loss | 55M USD | Medium |
| 2025/06/30 | Other special charges | Other | -7M USD | Medium |
| 2025/06/30 | Special income/charges | Other | 3M USD | Medium |
| 2025/06/30 | Write-off | Impairment | -1M USD | Medium |
| 2024/06/30 | Asset sale gain/loss | Asset sale gain/loss | -3M USD | Medium |
| 2024/06/30 | Special income/charges | Other | 34K USD | Medium |
| 2023/06/30 | Asset impairment | Impairment | -82M USD | Medium |
| 2023/06/30 | Asset sale gain/loss | Asset sale gain/loss | -151K USD | Medium |
| 2023/06/30 | Business sale gain/loss | Asset sale gain/loss | 3M USD | Medium |
| 2023/06/30 | Special income/charges | Other | -86M USD | Medium |
| 2023/06/30 | Write-off | Impairment | -856K USD | Medium |
| 2022/06/30 | Asset sale gain/loss | Asset sale gain/loss | 6M USD | Medium |
| 2022/06/30 | Other special charges | Other | -367K USD | Medium |
| 2022/06/30 | Special income/charges | Other | -132K USD | Medium |
| 2022/06/30 | Write-off | Impairment | -132K USD | Medium |
| 2021/06/30 | Other special charges | Other | -330K USD | Medium |
| 2026/03/31 | Asset impairment | Impairment | -260M USD | Medium |
| 2026/03/31 | Asset sale gain/loss | Asset sale gain/loss | 365K USD | Medium |
| 2025/12/31 | Asset sale gain/loss | Asset sale gain/loss | -91M USD | Medium |
| 2025/12/31 | Other special charges | Other | -88M USD | Medium |
| 2025/12/31 | Special income/charges | Other | -113M USD | Medium |
| 2025/12/31 | Write-off | Impairment | -25M USD | Medium |
| 2025/09/30 | Asset impairment | Impairment | -13M USD | Medium |
| 2025/09/30 | Asset sale gain/loss | Asset sale gain/loss | 517M USD | Medium |
| 2025/09/30 | Special income/charges | Other | -13M USD | Medium |
| 2025/06/30 | Asset impairment | Impairment | -6M USD | Medium |
| 2025/06/30 | Asset sale gain/loss | Asset sale gain/loss | 46M USD | Medium |
| 2025/06/30 | Special income/charges | Other | 9M USD | Medium |
| 2025/06/30 | Write-off | Impairment | -6M USD | Medium |
| 2025/03/31 | Asset sale gain/loss | Asset sale gain/loss | 5M USD | Medium |
| 2025/03/31 | Special income/charges | Other | 1M USD | Medium |
| 2025/03/31 | Write-off | Impairment | -75K USD | Medium |
| 2024/12/31 | Asset impairment | Impairment | -408K USD | Medium |
| 2024/12/31 | Asset sale gain/loss | Asset sale gain/loss | -29M USD | Medium |
| 2024/12/31 | Other special charges | Other | -1M USD | Medium |
| 2024/12/31 | Special income/charges | Other | -538K USD | Medium |
| 2024/09/30 | Asset sale gain/loss | Asset sale gain/loss | 658K USD | Medium |
Ad placement
Which reported financials feed the models?
Financial DetailsShowing latest 5 / 13
| Period | Type | Revenue | Net Income | Adjusted net income | Free Cash Flow | Diluted EPS | Adjusted EPS |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | Annual | 501M USD | 87M USD | 42M USD | -295M USD | 0.39 | 0.19 |
| 2024/06/30 | Annual | 187M USD | -29M USD | -26M USD | -90M USD | -0.29 | -0.26 |
| 2023/06/30 | Annual | 76M USD | -172M USD | -5M USD | -110M USD | -3.14 | -0.1 |
| 2022/06/30 | Annual | 59M USD | -420M USD | -425M USD | -332M USD | -10.25 | -10.39 |
| 2021/06/30 | Annual | - | - | - | - | - | - |
Where does this data come from?
Open to inspect field-level SEC EDGAR source, filing form, and derived notes.
SEC EDGAR
Where does this data come from?
Open to inspect field-level SEC EDGAR source, filing form, and derived notes.
Frequently asked questions
Quick notes on price-implied expectations, model differences, and source data.
What is IREN Limited's intrinsic value?
IREN Limited's intrinsic value on TickerVal is reviewed through DCF outputs, reverse DCF implied growth, EV/EBITDA, P/FCF, valuation assumptions, and financial trends from public filings.
How is IREN valued on TickerVal?
TickerVal values IREN by comparing intrinsic value models, DCF and reverse DCF assumptions, cash-flow multiples, earnings-power references, and reported financial trends.
What does the current stock price imply?
The reverse DCF view estimates the free-cash-flow growth path implied by the current stock price under stated discount-rate and terminal-growth assumptions.
Which valuation models are used?
TickerVal uses DCF, reverse DCF, Owner Earnings, EPV, Graham Number, EV/EBITDA, P/FCF, P/B, P/S, and other model references where the underlying data is available.
Is this investment advice?
No. TickerVal does not provide investment advice, ratings, price targets, or buy/sell recommendations.
Early supporter list
Get notified as TickerVal adds saved assumptions.
Join the research reference list for product updates, model notes, and transparent assumption workflows.
Ad placement